Immediate Impact

1 from Science/Nature 60 standout
Sub-graph 1 of 24

Citing Papers

Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Decoding the spatiotemporal heterogeneity of tumor-associated macrophages
2024 Standout
2 intermediate papers

Works of Phillip G. Claringbold being referenced

NeuroEndocrine Tumor Therapy with Lutetium-177-octreotate and Everolimus (NETTLE): A Phase I Study
2015
131 I-Anti CD20 Radioimmunotherapy of Relapsed or Refractory Non-Hodgkins Lymphoma: A Phase II Clinical Trial of a Nonmyeloablative Dose Regimen of Chimeric Rituximab Radiolabeled in a Hospital
2003
and 2 more

Author Peers

Author Last Decade Papers Cites
Phillip G. Claringbold 514 503 404 11 667
Christopher Uebleis 332 375 296 21 778
Geert Ensing 305 343 201 14 635
Maribel Lopera Sierra 440 497 342 24 616
Jan-Paul Esser 478 595 413 6 738
WH Bakker 444 573 364 16 764
Marianne E. Pavel 454 542 355 11 718
Camilla Bardram Johnbeck 372 399 266 20 805
H. Caillet 392 360 278 14 695
Torjan Haslerud 432 448 338 21 633
Tilmann Schumacher 354 428 268 6 591

All Works

Loading papers...

Rankless by CCL
2026